Perform

Perform is Bowery Clinic’s body-composition troche combining AOD-9604, CJC-1295, and Ipamorelin. The formula is built around two related but distinct ideas: AOD-9604 is a fragment derived from the lipolytic region of human growth hormone and has been researched for fat-metabolism activity, while CJC-1295 and Ipamorelin stimulate endogenous growth-hormone signaling through different receptors. CJC-1295 has human data showing sustained increases in GH and IGF-1 clinical study, and Ipamorelin has human pharmacodynamic data showing growth-hormone release study. AOD-9604 has preclinical metabolic research supporting its original fat-metabolism rationale research.

Perform is intended to support fat-metabolism and body-composition goals without relying on appetite suppression as the primary mechanism. AOD-9604 was designed from a region of growth hormone associated with lipolysis and produced metabolic effects in animal research study. CJC-1295 and Ipamorelin increase the body’s own growth-hormone signaling, which may support recovery and lean-body-mass goals when combined with resistance training and adequate protein. The medspa positioning should focus on gradual changes in body composition, waistline, recovery, and metabolic wellness rather than promising a specific amount of weight loss.

Perform should be prescribed only after a clinician reviews the patient’s endocrine and metabolic history. Because CJC-1295 and Ipamorelin both increase growth-hormone signaling, The formula should not be combined with other growth-hormone-axis therapies unless the prescribing clinician intentionally designs the combination. Potential concerns can include headache, fluid retention, tingling, injection-independent systemic effects from increased GH/IGF-1 signaling, and changes in glucose handling. The troche route also has its own tolerability and absorption considerations. AOD-9604 has a smaller modern human evidence base than commonly used weight-management drugs, so the safest approach is a defined treatment window, realistic expectations, and reassessment based on benefit and tolerability.

Perform is best evaluated over 8–12 weeks for body-composition goals. Sleep, recovery, or training-related changes may be noticed within the first 2–4 weeks, while changes in waist measurements or fat distribution develop more gradually. Fuller progress is generally easier to judge after 3–6 months of consistent treatment, nutrition, and resistance training.

Bowery Clinic peptides are higher-strength and clinically dosed compared to most research facilities that use much lower concentrations. They are compounded by licensed 503A pharmacies with physician oversight and sterile quality standards, prioritizing real therapeutic outcomes over cheaper, unregulated research-grade products, and come fully prepared and ready for use — no mixing or reconstitution needed.

Yes. All pharmacies in our network are fully licensed in the states where they operate and comply with all state board of pharmacy regulations. Unlike many peptide clinics, we partner exclusively with FDA-registered U.S. pharmacies that undergo rigorous evaluation and compliance checks.

Every patient receives treatment plans developed and monitored by licensed providers. This includes safe titration of dosages and ongoing medical oversight tailored to individual needs.

Injections deliver the medication directly into your system. This makes the absorption more consistent and effective. Troches are small dissolvable lozenges that sit in your mouth until they melt, slowly releasing medication through the lining of your cheek or under your tongue.